Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity

Martin L Duennwald1, Susan Lindquist

  • 1The Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.

Genes & Development
|November 19, 2008
PubMed

Insights

Protein misfolding causes neurodegenerative diseases like Huntington's disease (HD). This study reveals that polyglutamine (polyQ) expansion impairs endoplasmic reticulum-associated degradation (ERAD), a key protein quality control pathway, contributing to toxicity.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Protein misfolding is implicated in neurodegenerative diseases.
  • Abnormally long polyglutamine (polyQ) expansions in proteins cause disorders like Huntington's disease (HD).
  • The precise triggers of polyQ toxicity remain unclear despite known cellular pathway impairments in HD.

Purpose of the Study:

  • To investigate the early cellular defects caused by polyQ-expanded huntingtin (htt) fragments.
  • To elucidate the mechanisms underlying polyQ toxicity in neurodegenerative conditions.
  • To identify potential therapeutic targets for polyQ-related disorders.

Main Methods:

  • Utilized yeast and neuron-like PC12 cells expressing polyQ-expanded htt fragments.
  • Assessed endoplasmic reticulum (ER)-associated degradation (ERAD) function.
  • Investigated the interaction between polyQ-expanded htt and ERAD components (Npl4, Ufd1, p97).

Main Results:

  • PolyQ-expanded htt fragments caused a specific and drastic defect in ERAD in both yeast and PC12 cells.
  • The essential ERAD proteins Npl4, Ufd1, and p97 were found to be entrapped by polyQ-expanded htt fragments.
  • Overexpression of Npl4 and Ufd1 alleviated polyQ toxicity in these cellular models.

Conclusions:

  • Impaired ER protein homeostasis is a significant and conserved contributor to polyQ toxicity.
  • ERAD dysfunction is an early and critical event in polyQ-induced neurodegeneration.
  • Targeting ERAD components may offer a therapeutic strategy for Huntington's disease and other polyQ disorders.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...